- Home
- ITIC vs TKNO Comparison
ITIC vs TKNO Comparison
Compare ITIC & TKNO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ITIC
- TKNO
- Stock Information
- Founded
- ITIC 1972
- TKNO 1996
- Country
- ITIC United States
- TKNO United States
- Employees
- ITIC N/A
- TKNO N/A
- Industry
- ITIC Specialty Insurers
- TKNO Medicinal Chemicals and Botanical Products
- Sector
- ITIC Finance
- TKNO Health Care
- Exchange
- ITIC Nasdaq
- TKNO Nasdaq
- Market Cap
- ITIC 404.7M
- TKNO 390.7M
- IPO Year
- ITIC N/A
- TKNO 2021
- Fundamental
- Price
- ITIC $228.05
- TKNO $8.07
- Analyst Decision
- ITIC
- TKNO Buy
- Analyst Count
- ITIC 0
- TKNO 2
- Target Price
- ITIC N/A
- TKNO $5.00
- AVG Volume (30 Days)
- ITIC 12.7K
- TKNO 324.6K
- Earning Date
- ITIC 02-11-2025
- TKNO 03-10-2025
- Dividend Yield
- ITIC 6.95%
- TKNO N/A
- EPS Growth
- ITIC 22.45
- TKNO N/A
- EPS
- ITIC 15.10
- TKNO N/A
- Revenue
- ITIC $241,018,000.00
- TKNO $36,347,000.00
- Revenue This Year
- ITIC N/A
- TKNO $3.47
- Revenue Next Year
- ITIC N/A
- TKNO $12.07
- P/E Ratio
- ITIC $15.10
- TKNO N/A
- Revenue Growth
- ITIC 1.93
- TKNO N/A
- 52 Week Low
- ITIC $146.41
- TKNO $1.16
- 52 Week High
- ITIC $290.40
- TKNO $9.72
- Technical
- Relative Strength Index (RSI)
- ITIC 39.00
- TKNO 49.91
- Support Level
- ITIC $225.24
- TKNO $7.15
- Resistance Level
- ITIC $231.29
- TKNO $8.53
- Average True Range (ATR)
- ITIC 6.06
- TKNO 0.75
- MACD
- ITIC 0.26
- TKNO -0.14
- Stochastic Oscillator
- ITIC 58.01
- TKNO 38.06
About ITIC Investors Title Company
Investors Title Co operates primarily in the title insurance and exchange services sectors. The title insurance segment, conducted through ITIC and NITIC, offers title insurance policies for residential, commercial, and industrial properties in around 22 states and the District of Columbia, with a focus on the eastern United States. The title insurance segment primarily issues title insurance policies through approved attorneys from underwriting offices and through independent issuing agents. Title insurance policies insure titles to real estate.n The Title Insurance segment contributes the majority of the company's revenue.
About TKNO Alpha Teknova Inc.
Alpha Teknova Inc provides critical reagents that enable the discovery, development, and production of biopharmaceutical products such as drug therapies, novel vaccines, and molecular diagnostics. Its product offerings include pre-poured media plates for cell growth and cloning, liquid cell culture media and supplements for cellular expansion, and molecular biology reagents for sample manipulation, resuspension, and purification. It derives maximum revenue from United States.